News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Maxygen, Inc. (MAXY) Announces $10 Million Stock Repurchase Program


6/1/2011 1:01:15 PM

Maxygen, Inc. (Nasdaq:MAXY), a biotechnology company, today announced a stock repurchase program under which the company may purchase up to $10.0 million of its common stock through December 31, 2011. Since December 2009, Maxygen has repurchased approximately 10.0 million shares of its common stock at an aggregate cost of approximately $54.1 million.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES